PET/Computed Tomography in Breast Cancer: Can It Aid in Developing a Personalized Treatment Design?

Sumeet Suresh Malapure; Kalpa Jyoti Das; Rakesh Kumar

doi:10.1016/j.cpet.2016.02.006

PET/Computed Tomography in Breast Cancer: Can It Aid in Developing a Personalized Treatment Design?

Sumeet Suresh Malapure, Kalpa Jyoti Das, Rakesh Kumar

Research output: Contribution to journal › Review article › peer-review

2 Citations (Scopus)

Abstract

PET with fluorodeoxyglucose (FDG-PET)/computed tomography (CT) imaging has significantly improved the management of breast cancer. FDG, however, is not tumor-specific and various image interpretation pitfalls may occur due to false-positive and false-negative causes of FDG uptake. PET/CT imaging with more specific radiopharmaceuticals may provide useful information about the pathophysiology in such cases. In the present article, we reviewed the use of whole-body FDG-PET/CT and ¹⁸F-16α-17β-Fluoroestradiol PET/CT imaging to determine if these can be used to develop personalized treatment design for the better management of breast cancer.

Original language	English
Pages (from-to)	297-303
Number of pages	7
Journal	PET Clinics
Volume	11
Issue number	3
DOIs	https://doi.org/10.1016/j.cpet.2016.02.006
Publication status	Published - 01-07-2016
Externally published	Yes

All Science Journal Classification (ASJC) codes

Radiation
Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cpet.2016.02.006

Cite this

@article{d91346c3bc884a1da30dd7186b3e1f60,

title = "PET/Computed Tomography in Breast Cancer: Can It Aid in Developing a Personalized Treatment Design?",

abstract = "PET with fluorodeoxyglucose (FDG-PET)/computed tomography (CT) imaging has significantly improved the management of breast cancer. FDG, however, is not tumor-specific and various image interpretation pitfalls may occur due to false-positive and false-negative causes of FDG uptake. PET/CT imaging with more specific radiopharmaceuticals may provide useful information about the pathophysiology in such cases. In the present article, we reviewed the use of whole-body FDG-PET/CT and 18F-16α-17β-Fluoroestradiol PET/CT imaging to determine if these can be used to develop personalized treatment design for the better management of breast cancer.",

author = "{Suresh Malapure}, Sumeet and Das, {Kalpa Jyoti} and Rakesh Kumar",

year = "2016",

month = jul,

day = "1",

doi = "10.1016/j.cpet.2016.02.006",

language = "English",

volume = "11",

pages = "297--303",

journal = "PET Clinics",

issn = "1556-8598",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - PET/Computed Tomography in Breast Cancer

T2 - Can It Aid in Developing a Personalized Treatment Design?

AU - Suresh Malapure, Sumeet

AU - Das, Kalpa Jyoti

AU - Kumar, Rakesh

PY - 2016/7/1

Y1 - 2016/7/1

N2 - PET with fluorodeoxyglucose (FDG-PET)/computed tomography (CT) imaging has significantly improved the management of breast cancer. FDG, however, is not tumor-specific and various image interpretation pitfalls may occur due to false-positive and false-negative causes of FDG uptake. PET/CT imaging with more specific radiopharmaceuticals may provide useful information about the pathophysiology in such cases. In the present article, we reviewed the use of whole-body FDG-PET/CT and 18F-16α-17β-Fluoroestradiol PET/CT imaging to determine if these can be used to develop personalized treatment design for the better management of breast cancer.

AB - PET with fluorodeoxyglucose (FDG-PET)/computed tomography (CT) imaging has significantly improved the management of breast cancer. FDG, however, is not tumor-specific and various image interpretation pitfalls may occur due to false-positive and false-negative causes of FDG uptake. PET/CT imaging with more specific radiopharmaceuticals may provide useful information about the pathophysiology in such cases. In the present article, we reviewed the use of whole-body FDG-PET/CT and 18F-16α-17β-Fluoroestradiol PET/CT imaging to determine if these can be used to develop personalized treatment design for the better management of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84963954460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963954460&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2016.02.006

DO - 10.1016/j.cpet.2016.02.006

M3 - Review article

C2 - 27321033

AN - SCOPUS:84963954460

SN - 1556-8598

VL - 11

SP - 297

EP - 303

JO - PET Clinics

JF - PET Clinics

IS - 3

ER -

PET/Computed Tomography in Breast Cancer: Can It Aid in Developing a Personalized Treatment Design?

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this